Klaus Bonaventura

Summary

Affiliation: Klinikum Ernst von Bergmann
Country: Germany

Publications

  1. ncbi Cost-effectiveness of paclitaxel-coated balloon angioplasty and paclitaxel-eluting stent implantation for treatment of coronary in-stent restenosis in patients with stable coronary artery disease
    Klaus Bonaventura
    Department of Cardiology, Angiology, Klinikum Ernst von Bergmann, Potsdam, Germany
    Clin Res Cardiol 101:573-84. 2012
  2. ncbi Antiplatelet therapy in the era of percutaneous coronary intervention with drug-eluting balloons
    Klaus Bonaventura
    Department of Cardiology, Angiology, and Conservative Intensive Care, Heart, Thorax and Vascular Center, Klinikum Ernst von Bergmann, Potsdam, Germany
    EuroIntervention 7:K106-11. 2011
  3. ncbi Potential lifetime cost-effectiveness of catheter-based renal sympathetic denervation in patients with resistant hypertension
    Marc Dorenkamp
    Department of Cardiology, Charite Universitatsmedizin Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany
    Eur Heart J 34:451-61. 2013
  4. ncbi Direct costs and cost-effectiveness of dual-source computed tomography and invasive coronary angiography in patients with an intermediate pretest likelihood for coronary artery disease
    Marc Dorenkamp
    Department of Cardiology, Charite Universitatsmedizin Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13553 Berlin, Germany
    Heart 98:460-7. 2012

Detail Information

Publications4

  1. ncbi Cost-effectiveness of paclitaxel-coated balloon angioplasty and paclitaxel-eluting stent implantation for treatment of coronary in-stent restenosis in patients with stable coronary artery disease
    Klaus Bonaventura
    Department of Cardiology, Angiology, Klinikum Ernst von Bergmann, Potsdam, Germany
    Clin Res Cardiol 101:573-84. 2012
    ..Recent studies have demonstrated the safety and efficacy of drug-coated balloon (DCB) angioplasty for the treatment of coronary in-stent restenosis (ISR). The cost-effectiveness of this practice is unknown...
  2. ncbi Antiplatelet therapy in the era of percutaneous coronary intervention with drug-eluting balloons
    Klaus Bonaventura
    Department of Cardiology, Angiology, and Conservative Intensive Care, Heart, Thorax and Vascular Center, Klinikum Ernst von Bergmann, Potsdam, Germany
    EuroIntervention 7:K106-11. 2011
    ..The protocols of DEB studies suggest that the dual antiplatelet therapy with aspirin and clopidogrel of four weeks after DEB is safe and effective...
  3. ncbi Potential lifetime cost-effectiveness of catheter-based renal sympathetic denervation in patients with resistant hypertension
    Marc Dorenkamp
    Department of Cardiology, Charite Universitatsmedizin Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany
    Eur Heart J 34:451-61. 2013
    ..We aimed to determine the cost-effectiveness of this approach separately for men and women of different ages...
  4. ncbi Direct costs and cost-effectiveness of dual-source computed tomography and invasive coronary angiography in patients with an intermediate pretest likelihood for coronary artery disease
    Marc Dorenkamp
    Department of Cardiology, Charite Universitatsmedizin Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13553 Berlin, Germany
    Heart 98:460-7. 2012
    ....